While some optimists are convinced a cure for cancer is less than a decade away, the prediction has been scoffed at by others who describe the timeline as ambitious, if not downright unrealistic, reports Business Insider.
Last week Dario Amodei, the CEO of Anthropic – the Californian-based artificial intelligence research and safety company best known for developing Claude, a family of large language models and conversational AI assistants – confidently suggested that a cure to end the world’s most dreaded disease was less than 10 years away.
In a 42-minute IPO roadshow video released by the company (it’s due to launch on the stock exchange this week) Amodei made the audacious prediction that “cancer, Alzheimer’s, heart disease, mental illness – these will be relics of the past in, I think, less than a decade”.
The claim that all of those diseases, which have bedevilled medicine’s best minds for centuries, will be suddenly cured by AI, riled some AI naysayers and physicians, who took to X to voice their disbelief.
“Curing cancer, Alzheimer’s and mental illnesses can definitely benefit from AI. But that is impossible in just 10 years,” said Karl Lauterbach, Germany’s former Health Minister, on X.
“Unclear whether people like @DarioAmodei know so little about medicine or are deliberately misleading the public,” he added.
Melinda B. Chu, an AI medical researcher with an MD from Saint Louis University in the US, said Amodei had made those predictions just to stoke hype for his company.
“Anthropic has done nothing to suggest they themselves will contribute meaningfully to these goals,” she said.
Amodei, who has frequently said how AI could be misused by bad actors, has sought to soften his doomer reputation by, in part, highlighting AI’s potential benefit to medicine.
Anthropic has moved to expand its reach into drug development by buying several biotech start-ups, including a one-person company focused on developing treatments for muscular dystrophy.
In an October blog post, the company said it had “begun drug discovery efforts of our own”. It had also opened a “wet lab” to explore how AI technology can support research in fundamental biology, a person familiar with the matter said.
In an August X post, Amodei said that the best way to win over AI sceptics was for AI companies to “actually cure cancer”. In that post, however, he also noted that “saying that AI will cure cancer is more a cliché than it is inspiring, and most people think it is deceptive”.
See more from MedicalBrief archives:
New AI tool IDs cancer, speeds up diagnosis
Cancer researchers edge closer to cures, better treatment
Cancer more survivable than ever before
Chinese gene-editing scientist aims to cure Alzheimer’s
Science, not corporate zeal, must drive search for Alzheimer’s drug
